The generic drug industry has warned that US tariffs on pharmaceuticals risk causing shortages of medicines including cancer treatments, and that manufacturers might stop making products that become unprofitable as a result.
仿制藥行業警告稱，美國對藥品征收關稅可能導致包括癌癥治療在內的藥品短缺，制造商可能會停止生產因此變得無利可圖的產品。
您已閱讀5%（282字），剩余95%（5569字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。